Avelumab flat dose regimen: Justification for use in advanced renal cell carcinoma (aRCC) Meeting Abstract
| Authors: | Haanen, J. B. A. G.; Masters, J. C.; Huang, B.; Choueiri, T. K.; Motzer, R. J.; Khandelwal, A.; Dai, H.; di Pietro, A.; Brar, S.; Rini, B. I.; Albiges, L.; Larkin, J. M. G. |
| Abstract Title: | Avelumab flat dose regimen: Justification for use in advanced renal cell carcinoma (aRCC) |
| Meeting Title: | 2020 ASCO-SITC Clinical Immuno-Oncology Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2020 Feb 6-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-02-10 |
| Language: | English |
| ACCESSION: | WOS:000529994300034 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.5_suppl.32 |
| Notes: | Meeting Abstract: 32 -- Source: Wos |
